Metastatic Colorectal Cancer Market Size Anticipated to Expand at a CAGR of 2.6% (2020-30) in the 7MM in the coming decade - DelveInsight
Metastatic Colorectal Cancer Market Report lays down a comprehensive view of the mCRC market trends covering key pharmaceutical companies in the market, upcoming as well as Metastatic Colorectal Cancer marketed therapies, unmet needs, prevailing constraints and the factors driving the Metastatic Colorectal Cancer market size growth.
The report covers the Metastatic Colorectal Cancer Epidemiological analysis focusing on the mCRC incidence and diagnosed patient pool segmented on the basis of several factors, as well as the upcoming trends of the mCRC epidemiology that is going to affect the overall patient pool and the Metastatic Colorectal Cancer Market outlook.
Major Advancement in Preventing Neutropenia, Says Trialist
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
23 Jan 2021 / 04:39 H.
By Nancy Lapid
Jan 22 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Virus variant found in California drives SoCal surge
A new variant of the coronavirus appears to account for the recent surge of cases in southern California, researchers say. The variant, called CAL.20C, accounted for fewer than one in every 1,000 COVID-19 cases in Los Angeles county in July. It was not detected again until October, but by December accounted for 36% of cases, researchers from Cedars-Sinai Medical Center in Los Angeles reported on Wednesday on medRxiv ahead of peer review. The CAL.20C variant is distinct from those discovered in the UK, South Africa and Brazil. It carries five mutations: three in the spike protein, which the virus uses to break into cells, and two in other parts of the virus. CAL.20C has also been detected in
Article content
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Virus variant found in California drives SoCal surge
We apologize, but this video has failed to load.
Try refreshing your browser, or California virus variant driving surge around LA; smell training advised for lingering problem Back to video
A new variant of the coronavirus appears to account for the recent surge of cases in southern California, researchers say. The variant, called CAL.20C, accounted for fewer than one in every 1,000 COVID-19 cases in Los Angeles county in July. It was not detected again until October, but by December accounted for 36% of cases, researchers from Cedars-Sinai Medical Center in Los Angeles reported on Wednesday on medRxiv ahead of peer review. The CAL.20C variant is distinct from those discovered in the UK, South Africa and Brazil. It carries five
Recommendation based on positive results from the DESTINY-Breast01 trial, which showed durable responses in patients with previously treated disease
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s trastuzumab deruxtecan has been recommended for conditional marketing authorisation in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 based regimens.
In Europe, approximately 520,000 cases of breast cancer in women are diagnosed annually, with roughly one in five cases being HER2 positive.
1-2 The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.
vimarsana © 2020. All Rights Reserved.